Dechra Pharmaceuticals PLC Price on March 7, 2023

DPHAYDelisted Stock  USD 93.78  0.00  0.00%   
If you're considering investing in Dechra Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Dechra Pharmaceuticals stands at 93.78, as last reported on the 1st of December, with the highest price reaching 93.78 and the lowest price hitting 93.78 during the day. We have found seventeen technical indicators for Dechra Pharmaceuticals PLC, which you can use to evaluate the volatility of the firm. Please confirm Dechra Pharmaceuticals' Mean Deviation of 0.8818, standard deviation of 3.11, and Coefficient Of Variation of 5226.92 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Dechra Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
DPHAY
Based on monthly moving average Dechra Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dechra Pharmaceuticals by adding Dechra Pharmaceuticals to a well-diversified portfolio.

Dechra Pharmaceuticals Valuation on March 7, 2023

It is possible to determine the worth of Dechra Pharmaceuticals on a given historical date. On March 7, 2023 Dechra was worth 69.14 at the beginning of the trading date compared to the closed value of 68.45. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Dechra Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Dechra Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Dechra Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Dechra Pharmaceuticals' related companies.
 Open High Low Close Volume
  68.10    74.76    68.10    73.43    9,767  
03/07/2023
  69.14    69.14    68.45    68.45    1,334  
  68.75    68.75    68.45    68.45    36.00  
Backtest Dechra Pharmaceuticals  |  Dechra Pharmaceuticals History  |  Dechra Pharmaceuticals Valuation   PreviousNext  
Open Value
69.14
68.45
Closing Value
69.14
Upside

Dechra Pharmaceuticals Trading Date Momentum on March 7, 2023

On March 08 2023 Dechra Pharmaceuticals PLC was traded for  68.45  at the closing time. The highest daily price throughout the period was 68.75  and the lowest price was  68.45 . The daily volume was 36.0. The net trading volume on 03/08/2023 did not affect price variability. The overall trading delta to current closing price is 8.15% .

Dechra Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Dechra Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Dechra Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Dechra financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Dechra Pharmaceuticals Pink Sheet history

Dechra Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Dechra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Dechra Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Dechra Pharmaceuticals stock prices may prove useful in developing a viable investing in Dechra Pharmaceuticals
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom. Dechra Pharmaceuticals operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 1699 people.

Dechra Pharmaceuticals Pink Sheet Technical Analysis

Dechra Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Dechra Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Dechra Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Dechra Pharmaceuticals Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Dechra Pharmaceuticals PLC cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Dechra Pharmaceuticals December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how Dechra Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dechra Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Dechra Pharmaceuticals pink sheet market strength indicators, traders can identify Dechra Pharmaceuticals PLC entry and exit signals to maximize returns

Dechra Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Dechra Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Dechra Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Dechra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Dechra Pink Sheet

If you are still planning to invest in Dechra Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dechra Pharmaceuticals' history and understand the potential risks before investing.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years